Metabolic Syndrome as a Factor Affecting on Intima-Media Thickness in Patients with Rheumatoid Arthritis

Lyudmila Gennadievna Turgunova; Anna Andreevna Shalygina; Lyazat Kataevna Ibrayeva; Anar Akylbecovna Turmuhambetova

doi:10.3889/oamjms.2021.5943

Authors

Lyudmila Gennadievna Turgunova Department of Internal Medicine, Karaganda Medical University, Karaganda, Kazakhstan
Anna Andreevna Shalygina Karaganda Medical University, Karaganda, Kazakhstan
Lyazat Kataevna Ibrayeva Karaganda Medical University, Karaganda, Kazakhstan
Anar Akylbecovna Turmuhambetova Department of Strategic Development, Karaganda Medical University, Research and International Collaboration, Karaganda, Kazakhstan

DOI:

https://doi.org/10.3889/oamjms.2021.5943

Keywords:

Rheumatoid arthritis, Metabolic syndrome, Intima-media thickness

Abstract

AIM: The aim of the study was to assess the association of the thickness of the intima-media complex with metabolic syndrome (MetS) and the degree of disease activity in patients with rheumatoid arthritis (RA).

MATERIALS AND METHODS: The study included 101 patients with RA. All patients underwent a biochemical examination, the presence of MetS was determined, and the carotid thickness of the intima-media was determined. Statistical processing was performed using SPSS for Windows, version 18.0.

RESULTS: Among 101 patients with RA, 41 (40.5%) had MetS. The frequency of detecting an increased value of the intima-media complex thickness was significantly higher in the group with MetS (n = 31 [75.6%]) than in the group without MetS (n = 21 [35.0%] p ≤ 0.0001). In the group of patients with MetS, the median carotid intima-media thickness (CIMT) was 1.2 mm, while this indicator in the group without MetS was 0.78 mm (U = 727, p = 0.001). In the regression model, MetS (B = 1.05; p = 0.027) and DAS28-ESR (B = 0.506; p = 0.021) were influenced by CIMT.

CONCLUSIONS: The results of our study show the effect of MetS and RA activity on the increase of intima-media thickness.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

van Halm VP, Peters MJ, Voskuyl AE, Boers M, Lems WF, Visser M, et al. Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: A cross-sectional study, the CARRE investigation. Ann Rheum Dis. 2009;68(9):1395-400. https://doi.org/10.1136/ard.2008.094151 PMid:18697775 DOI: https://doi.org/10.1136/ard.2008.094151

del Rincón I, Polak JF, O’Leary DH, Battafarano DF, Erikson JM, Restrepo JF, et al. Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis. Ann Rheum Dis. 2015;74(6):1118-23. https://doi.org/10.1136/annrheumdis-2013-205058 PMid:24845391 DOI: https://doi.org/10.1136/annrheumdis-2013-205058

Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690-7. https://doi.org/10.1002/art.24092 PMid:19035419 DOI: https://doi.org/10.1002/art.24092

Fischer LM, Schlienger RG, Matter C, Jick H, Meier CR. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004;93(2):198-200. https://doi.org/10.1016/j.amjcard.2003.09.037 PMid:14715346 DOI: https://doi.org/10.1016/j.amjcard.2003.09.037

Reiss AB, Silverman A, Khalfan M, Vernice NA, Kasselman LJ, Carsons SE, et al. Accelerated atherosclerosis in rheumatoid arthritis: Mechanisms and treatment. Curr Pharm Des. 2019;25(9):969-86. https://doi.org/10.2174/1381612825666190430113212 PMid:31208307 DOI: https://doi.org/10.2174/1381612825666190430113212

Arida A, Protogerou AD, Kitas GD, Sfikakis PP. Systemic inflammatory response and atherosclerosis: The paradigm of chronic inflammatory rheumatic diseases. Int J Mol Sci. 2018;19(7):1890. https://doi.org/10.3390/ijms19071890 PMid:29954107 DOI: https://doi.org/10.3390/ijms19071890

Jung JM, Kwon DY, Han C, Park MH. Metabolic syndrome and early carotid atherosclerosis in the elderly. J Atheroscler Thromb. 2014;21(5):435-44. PMid:24477027 DOI: https://doi.org/10.5551/jat.18655

Gami AS, Witt BJ, Howard DE, Erwin PJ, Gami LA, Somers VK, et al. Metabolic syndrome and risk of incident cardiovascular events and death: A systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007;49(4):403-14. https://doi.org/10.1016/j.jacc.2006.09.032 PMid:17258085 DOI: https://doi.org/10.1016/j.jacc.2006.09.032

Zhang J, Fu L, Shi J, Chen X, Li Y, Ma B, et al. The risk of metabolic syndrome in patients with rheumatoid arthritis: A meta-analysis of observational studies. PLoS One. 2013;8(10):e78151. https://doi.org/10.1371/journal.pone.0078151 PMid:24205134 DOI: https://doi.org/10.1371/journal.pone.0078151

Rostom S, Mengat M, Lahlou R, Hari A, Bahiri R, Hajjaj- Hassouni N. Metabolic syndrome in rheumatoid arthritis: Case control study. BMC Musculoskelet Disord. 2013;14:147. https://doi.org/10.1186/1471-2474-14-147 PMid:23621997 DOI: https://doi.org/10.1186/1471-2474-14-147

Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196(2):756-63. https://doi.org/10.1016/j.atherosclerosis.2007.01.004 PMid:17266963 DOI: https://doi.org/10.1016/j.atherosclerosis.2007.01.004

Lorenz MW, Markus HS, Bots ML, Rosvall M, Sitzer M. Prediction of clinical cardiovascular events with carotid intima-media thickness: A systematic review and meta-analysis. Circulation. 2007;115(4):459-67. https://doi.org/10.1161/circulationaha.106.628875 PMid:17242284 DOI: https://doi.org/10.1161/CIRCULATIONAHA.106.628875

van Sijl AM, Peters MJ, Knol DK, de Vet HC, Gonzalez- Gay MA, Smulders YM, et al. Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: A meta-analysis. Semin Arthritis Rheum. 2011;40(5):389-97. https://doi.org/10.1016/j.semarthrit.2010.06.006 PMid:20889191 DOI: https://doi.org/10.1016/j.semarthrit.2010.06.006

Wah-Suarez MI, Galarza-Delgado DA, Azpiri-Lopez JR, Colunga- Pedraza IJ, Cardenas-de la Garza JA, Vera-Pineda R, et al. The best cardiovascular risk calculator to predict carotid plaques in rheumatoid arthritis patients. Clin Rheumatol. 2018;37(9):2373-80. https://doi.org/10.1007/s10067-018-4181-4 PMid:29967925 DOI: https://doi.org/10.1007/s10067-018-4181-4

Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost. 2015;113(5):916-30. https://doi.org/10.1160/th14-11-0921 PMid:25716931 DOI: https://doi.org/10.1160/TH14-11-0921

Zhou PA, Zhang CH, Chen YR, Li D, Song DY, Liu HM, et al. Association between metabolic syndrome and carotid atherosclerosis: A cross-sectional study in Northern China. Biomed Environ Sci. 2019;32(12):914-21. PMid:31918796

Cuspidi C, Sala C, Provenzano F, Tadic M, Gherbesi E, Grassi G, et al. Metabolic syndrome and subclinical carotid damage: A meta-analysis from population-based studies. J Hypertens. 2018;36(1):23-30. https://doi.org/10.1097/hjh.0000000000001575 PMid:29035943 DOI: https://doi.org/10.1097/HJH.0000000000001575

Uslu AU, Kucuk A, Balta S, Ozturk C, Arslan S, Tekin L, et al. The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(1):32-7. https://doi.org/10.1111/1756-185x.12851 PMid:27028097 DOI: https://doi.org/10.1111/1756-185X.12851

Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: A population-based study. Arthritis Rheum. 2005;52(3):722-32. https://doi.org/10.1002/art.20878 PMid:15751097 DOI: https://doi.org/10.1002/art.20878

Burggraaf B, van Breukelen-van der Stoep DF, de Vries MA, Klop B, van Zeben J, van de Geijn GM, et al. Progression of subclinical atherosclerosis in subjects with rheumatoid arthritis and the metabolic syndrome. Atherosclerosis. 2018;271:84-91. https://doi.org/10.1016/j.atherosclerosis.2018.02.019 PMid:29482038 DOI: https://doi.org/10.1016/j.atherosclerosis.2018.02.019

Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO 3rd, et al. 2010 Rheumatoid arthritis classification criteria: An American college of rheumatology/European league against rheumatism collaborative initiative. Arthritis Rheum. 2010;62(9):2569-81. https://doi.org/10.1002/art.27583 PMid:20872595 DOI: https://doi.org/10.1002/art.27583

Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315-24. https://doi.org/10.1002/art.1780310302 PMid:3358796 DOI: https://doi.org/10.1002/art.1780310302

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome--a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med. 2006;23(5):469-80. https://doi.org/10.1111/j.1464-5491.2006.01858.x PMid:16681555 DOI: https://doi.org/10.1111/j.1464-5491.2006.01858.x

Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502. https://doi.org/10.1093/clinchem/18.6.499 PMid:4337382 DOI: https://doi.org/10.1093/clinchem/18.6.499

Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, et al. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. Endorsed by the society for vascular medicine. J Am Soc Echocardiogr. 2008;21(2):93-111; quiz 189-90. https://doi.org/10.1016/j.echo.2007.11.011 PMid:18261694 DOI: https://doi.org/10.1016/j.echo.2007.11.011

Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam study. Circulation. 1997;96(5):1432-7. https://doi.org/10.1161/01.cir.96.5.1432 PMid:9315528 DOI: https://doi.org/10.1161/01.CIR.96.5.1432

O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med. 1999;340(1):14-22. https://doi.org/10.1056/nejm199901073400103 PMid:9878640 DOI: https://doi.org/10.1056/NEJM199901073400103

del Sol AI, Bots ML, Grobbee DE, Hofman A, Witteman JC. Carotid intima-media thickness at different sites: Relation to incident myocardial infarction; The Rotterdam study. Eur Heart J. 2002;23(12):934-40. https://doi.org/10.1053/euhj.2001.2965 PMid:12069447. DOI: https://doi.org/10.1053/euhj.2001.2965

Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44-8. https://doi.org/10.1002/art.1780380107 PMid:7818570. DOI: https://doi.org/10.1002/art.1780380107

Fransen J, Welsing P, Keijzer RD, Riel PV. Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity. Ann Rheum Dis 2004;62:151.

Pinto MRC, Kakehasi AM, Souza AJ, Tavares WC Jr., Rocha MA, Trant CG, et al. Methotrexate use, not interleukin 33, is associated with lower carotid intima-media thickness in patients with rheumatoid arthritis. Adv Rheumatol. 2019;59(1):15. https://doi.org/10.1186/s42358-019-0060-1 PMid:30944039 DOI: https://doi.org/10.1186/s42358-019-0060-1

Targońska-Stepniak B, Drelich-Zbroja A, Majdan M. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis. J Clin Rheumatol. 2011;17(5):249-55. https://doi.org/10.1097/rhu.0b013e3182290dbf PMid:21778898 DOI: https://doi.org/10.1097/RHU.0b013e3182290dbf

Beyazal MS, Erdoğan T, Devrimsel G, Türkyılmaz AK, Cüre MC, Beyazal M, et al. Relationship of osteoprotegerin to pulse wave velocity and carotid intima-media thickness in rheumatoid arthritis patients. Z Rheumatol. 2016;75(7):723-8. https://doi.org/10.1007/s00393-015-1675-1 PMid:26555551 DOI: https://doi.org/10.1007/s00393-015-1675-1

Adawi M, Firas S, Blum A. Rheumatoid arthritis and atherosclerosis. Isr Med Assoc J. 2019;21(7):460-3. PMid:31507121

Arida A, Protogerou AD, Konstantonis G, Fragiadaki K, Kitas GD, Sfikakis PP. Atherosclerosis is not accelerated in rheumatoid arthritis of low activity or remission, regardless of antirheumatic treatment modalities. Rheumatology (Oxford). 2017;56(6):934-9. https://doi.org/10.1093/rheumatology/kew506 PMid:28160488 DOI: https://doi.org/10.1093/rheumatology/kew506

Kim HJ, Kim MJ, Lee CK, Hong YH. Effects of methotrexate on carotid intima-media thickness in patients with rheumatoid arthritis. J Korean Med Sci. 2015;30(11):1589-96. https://doi.org/10.3346/jkms.2015.30.11.1589 PMid:26539002 DOI: https://doi.org/10.3346/jkms.2015.30.11.1589